Comparison

Abarelix European Partner

Item no. M13376-5mg
Manufacturer AbMole
CASRN 183552-38-7
Amount 5mg
Category
Type Chemicals
Specific against other
Purity >96%
Formula C72H95ClN14O14
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias R3827; PPI 149
Available
Target Information
LHRH/GnRH
Molecular Weight
1416, 06
Solubility
DMSO : ≥ 14.2 mg/mL
Bioactivity information
Abarelix (R3827) is the first approved antagonist for the study of GnRH in advanced prostate cancer.
Sequence:Ac-{d-2-Nal}-{d-4-Cpa}-{d-3-Pal}-S-{NMyr}-{d-Asp}-L-K(ipr)-P-{d-Ala}-NH2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close